CANF
Price
$1.91
Change
-$0.04 (-2.05%)
Updated
Apr 26, 6:59 PM EST
TPST
Price
$3.54
Change
+$0.06 (+1.72%)
Updated
Apr 26, 6:59 PM EST
12 days until earnings call
Ad is loading...

Analysis and predictions CANF vs TPST

Header iconCANF vs TPST Comparison
Open Charts CANF vs TPSTBanner chart's image
Can-Fite BioPharma
Price$1.91
Change-$0.04 (-2.05%)
Volume$1.4K
CapitalizationN/A
Tempest Therapeutics
Price$3.54
Change+$0.06 (+1.72%)
Volume$226.11K
CapitalizationN/A
View a ticker or compare two or three
CANF vs TPST Comparison Chart

Loading...

CANFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TPSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CANF vs. TPST commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Sell and TPST is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (CANF: $1.98 vs. TPST: $3.54)
Brand notoriety: CANF and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 47% vs. TPST: 38%
Market capitalization -- CANF: $10.3M vs. TPST: $78.65M
CANF [@Biotechnology] is valued at $10.3M. TPST’s [@Biotechnology] market capitalization is $78.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • CANF’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both CANF and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 5 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • CANF’s TA Score: 5 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CANF is a better buy in the short-term than TPST.

Price Growth

CANF (@Biotechnology) experienced а 0.00% price change this week, while TPST (@Biotechnology) price change was +14.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

CANF is expected to report earnings on Jun 01, 2023.

TPST is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CANF with price predictions.
OPEN
A.I.dvisor published
a Summary for TPST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TPST($78.6M) has a higher market cap than CANF($10.3M). CANF YTD gains are higher at: -10.000 vs. TPST (-19.545).
CANFTPSTCANF / TPST
Capitalization10.3M78.6M13%
EBITDAN/AN/A-
Gain YTD-10.000-19.54551%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CANF vs TPST: Fundamental Ratings
CANF
TPST
OUTLOOK RATING
1..100
8082
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5947
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANF's Valuation (29) in the Biotechnology industry is in the same range as TPST (54) in the Pharmaceuticals Major industry. This means that CANF’s stock grew similarly to TPST’s over the last 12 months.

CANF's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that CANF’s stock grew similarly to TPST’s over the last 12 months.

CANF's SMR Rating (98) in the Biotechnology industry is in the same range as TPST (99) in the Pharmaceuticals Major industry. This means that CANF’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (47) in the Pharmaceuticals Major industry is in the same range as CANF (59) in the Biotechnology industry. This means that TPST’s stock grew similarly to CANF’s over the last 12 months.

TPST's P/E Growth Rating (86) in the Pharmaceuticals Major industry is in the same range as CANF (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to CANF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANFTPST
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
CANFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TPSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CODYY16.060.89
+5.87%
Compagnie de Saint Gobain
RGP11.100.09
+0.82%
Resources Connection
BXBLY18.760.01
+0.05%
Brambles Ltd
LUGDF14.200.01
+0.04%
Lundin Gold
ELUT2.78-0.11
-3.81%
Elutia

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
+3.13%
ALDX - CANF
46%
Loosely correlated
-0.25%
TPST - CANF
27%
Poorly correlated
+1.72%
BCEL - CANF
26%
Poorly correlated
-6.43%
ORMP - CANF
26%
Poorly correlated
+6.96%
ARWR - CANF
25%
Poorly correlated
+1.14%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with MTNB. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+1.72%
MTNB - TPST
73%
Closely correlated
-1.43%
PHIO - TPST
49%
Loosely correlated
-3.40%
ORMP - TPST
30%
Poorly correlated
+6.96%
RLAY - TPST
30%
Poorly correlated
+3.49%
SWTX - TPST
30%
Poorly correlated
+3.01%
More